ES2161768T3 - Medicamento encapsulado. - Google Patents

Medicamento encapsulado.

Info

Publication number
ES2161768T3
ES2161768T3 ES94918588T ES94918588T ES2161768T3 ES 2161768 T3 ES2161768 T3 ES 2161768T3 ES 94918588 T ES94918588 T ES 94918588T ES 94918588 T ES94918588 T ES 94918588T ES 2161768 T3 ES2161768 T3 ES 2161768T3
Authority
ES
Spain
Prior art keywords
pct
date jan
sec
insoluble compound
practically insoluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94918588T
Other languages
English (en)
Inventor
Takehisa Hata
Fumio Shimojo
Kazutake Kado
Kyoko Ishii
Seiji Sawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2161768T3 publication Critical patent/ES2161768T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Abstract

ESTA INVENCION SE REFIERE A UNA DOSIS FARMACEUTICA ENCAPSULADA QUE CONTIENE UN COMPUESTO PRACTICAMENTE INSOLUBLE O SAL Y UN FLUIDO INTRACAPSULAR, Y/O UN SURFACTANTE Y/O UN DERIVADO DE CELULOSA. PRESENTA UNA MAYOR ABSORCION ORAL EN COMPARACION AL SISTEMA CONVENCIONAL YA QUE, AL LIBERARSE EL CONTENIDO DE LA CAPSULA DEL REVESTIMIENTO DE LA CAPSULA, EL COMPUESTO PRACTICAMENTE INSOLUBLE O SAL EXPERIMENTE UNA DISMINUCION DEL TAMAÑO DE LOS CRISTALES.
ES94918588T 1993-06-30 1994-06-28 Medicamento encapsulado. Expired - Lifetime ES2161768T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16098393 1993-06-30

Publications (1)

Publication Number Publication Date
ES2161768T3 true ES2161768T3 (es) 2001-12-16

Family

ID=15726345

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94918588T Expired - Lifetime ES2161768T3 (es) 1993-06-30 1994-06-28 Medicamento encapsulado.

Country Status (15)

Country Link
US (1) US5683716A (es)
EP (1) EP0706380B1 (es)
JP (1) JPH09501150A (es)
KR (1) KR960703335A (es)
CN (1) CN1087933C (es)
AT (1) ATE204163T1 (es)
AU (1) AU682192B2 (es)
CA (1) CA2165789A1 (es)
DE (1) DE69427981T2 (es)
DK (1) DK0706380T3 (es)
ES (1) ES2161768T3 (es)
GR (1) GR3036407T3 (es)
PT (1) PT706380E (es)
TW (1) TW360543B (es)
WO (1) WO1995001166A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
WO2001060353A1 (fr) * 2000-02-21 2001-08-23 Fujisawa Pharmaceutical Co., Ltd. Preparation liquide a absorbabilite amelioree
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
WO2002094173A2 (en) * 2001-05-22 2002-11-28 Euro-Celtique Tamper resistant oral dosage form
US20030077378A1 (en) * 2001-10-22 2003-04-24 Lou Wen Chin Hydroxypropyl cellulose encapsulation material
NZ584729A (en) * 2007-10-05 2012-12-21 Alzheimer S Inst Of America Inc Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer
JP5750278B2 (ja) * 2011-02-28 2015-07-15 東洋カプセル株式会社 カンデサルタンシレキセチルのカプセル充填用組成物
WO2014010008A1 (ja) * 2012-07-09 2014-01-16 東洋カプセル株式会社 カンデサルタンシレキセチルのカプセル充填用組成物
US11491088B2 (en) 2012-11-06 2022-11-08 CoLabs International Corporation Compositions containing a capsule with a moisturizing agent
US11724134B2 (en) 2012-11-06 2023-08-15 CoLabs International Corporation Compositions containing a cellulose derived capsule with a sunscreen active agent
US10322301B2 (en) 2012-11-06 2019-06-18 CoLabs International Corporation Compositions containing a cellulose derived capsule with a sunscreen active agent
US11690793B2 (en) 2012-11-06 2023-07-04 Colabs Int'l Corp. Composition containing a cellulose derived capsule with a sunscreen
US11707421B2 (en) 2012-11-06 2023-07-25 Colabs Int'l Corp. Compositions containing a flexible derived capsule with an active agent
JP2015536985A (ja) 2012-11-06 2015-12-24 コラブス インターナショナル コーポレーション 日焼け止めを含むセルロース由来カプセル含有組成物
EP3813786A4 (en) 2018-06-27 2022-06-29 Colabs International Corporation Compositions comprising silicon dioxide-based particles including one or more agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
KR920008948B1 (ko) * 1987-02-12 1992-10-12 니혼 덴네쯔 게이기 가부시끼가이샤 프린트 기판의 납땜방법 및 그의 장치
US5340591A (en) * 1992-01-24 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine

Also Published As

Publication number Publication date
PT706380E (pt) 2002-02-28
CN1127990A (zh) 1996-07-31
US5683716A (en) 1997-11-04
JPH09501150A (ja) 1997-02-04
EP0706380A1 (en) 1996-04-17
GR3036407T3 (en) 2001-11-30
KR960703335A (ko) 1996-08-17
DE69427981D1 (de) 2001-09-20
EP0706380B1 (en) 2001-08-16
AU682192B2 (en) 1997-09-25
TW360543B (en) 1999-06-11
CN1087933C (zh) 2002-07-24
DE69427981T2 (de) 2001-11-29
DK0706380T3 (da) 2001-10-08
ATE204163T1 (de) 2001-09-15
WO1995001166A1 (en) 1995-01-12
AU6984294A (en) 1995-01-24
CA2165789A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
ES2161768T3 (es) Medicamento encapsulado.
WO2003011204A3 (en) Drug delivery systems
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
DE59609926D1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
UA26455C2 (uk) Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DE69504509T2 (de) Thiazolidinderivate, ihre herstellung und medikamente, die sie enthalten
KR960000217A (ko) L- 카르니틴염과 이를 함유한 조성물
IT1240768B (it) Composizione farmaceutica contenente ranitidina sotto forma di capsule di gelatina.
DE69525649T2 (de) Lamotrigin haltiges arzneimittel
HUP9801414A2 (hu) Nátrium-alginátot és kálium-bikarbonátot tartalmazó folyékony vizes gyógyszerkészítmények
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
AU7775398A (en) Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
KR930702004A (ko) 세파로스포란 산 유도체를 함유하는 정제를 제조하기 위한 직접 압축 방법
FI951961A (fi) Tilidiinidivetyortofosfatti, menetelmä sen valmistamiseksi ja sitä sisältäviä farmaseuttisia valmisteita
FI963567A (fi) Diklofenakki-Na:a sisältävä depottabletti
DE59503283D1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
DE69616591D1 (de) Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
DE59403326D1 (de) Neue bishispidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
MY129255A (en) A new physical form of artemisinin and its use in the production of pharmaceuticals

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 706380

Country of ref document: ES